Athyrium Capital Management | Structured Investments in the Global Healthcare Sector Investor Login AOF I Portal AOF II Portal Home About Us Overview Our Funds Our History Approach Criteria Philosophy What is Structured Capital Case Study: Jazz Case Study: Verenium Case Study: Biofire Team Portfolio AOF II AOF I Previous Investments News Contact Us Structured Investments in the Global Healthcare Sector Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations. Athyrium advises funds with over $1.7 billion of committed capital. September 8, 2016 Apollo Endosurgery and Lpath Sign Merger Agreement September 6, 2016 Pharmaceutics International, Inc. Received $93 Million in Growth Capital August 9, 2016 Medicrea Announces 20 Million Financing to Support Commercial Expansion of Patient-Specific UNiD Rods for Spine Surgery July 21, 2016 Galenica to Acquire Relypsa to Strengthen its Business Unit, Vifor Pharma May 3, 2016 Relypsa Announces $150 Million Debt Financing March 3, 2016 Alvogen Announces Acquisition to Expand U.S. Business January 4, 2016 Halozyme Enters Into Agreement For $150 Million Non-Dilutive Royalty-Backed Debt Financing MORE About Us Athyrium is a specialized asset management company which advises funds with over $1.7 billion in committed capital. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations.... MORE AOF II Final Close AOF II $1,227,250,000 Limited Partnership Interests May 2015 Athyrium Newsletter Sign up for updates and news from Athyrium Capital Management. Your email will not be distributed or used for any third party purposes. © 2016 Athyrium Capital Management, LP. All rights reserved. Disclaimer